JPMorgan annonce des
JPMorgan annonce des distributions en espèces pour les FNB JPMorgan
November 25, 2024 07:00 ET | JPMorgan Asset Management (Canada) Inc.
TORONTO, 25 nov. 2024 (GLOBE NEWSWIRE) -- J. P. Morgan Asset Management (JPMAM)* a annoncé aujourd’hui les montants définitifs des distributions en espèces de novembre 2024 pour les FNB JPMorgan...
image001.png
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
November 25, 2024 07:00 ET | JPMorgan Asset Management (Canada) Inc.
TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- J. P. Morgan Asset Management (JPMAM)* today announced the final November 2024 cash distributions for the below listed JPMorgan ETFs.  The JPMorgan ETFs...
Announcement Potential Entering of Distribution Agreement with CICC and JPMorgan
September 13, 2024 05:28 ET | Garden stage Limited
Hong Kong, Sept. 13, 2024 (GLOBE NEWSWIRE) -- I Win Securities Limited (“I Win”), a wholly-owned subsidiaries of Garden Stage Limited (NASDAQ: GSIW) (“Garden Stage”), has been in advanced...
Carmell
Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
July 29, 2024 08:30 ET | Carmell Corporation
Carmell Corp (Nasdaq: CTCX) announced the appointment of Kendra Bracken-Ferguson as CEO effective July 30, 2024 with Rajiv Shukla continuing as Chairman.
exagen-logo-440x386-1.jpg
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
January 07, 2024 12:00 ET | Exagen Inc.
CARLSBAD, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announces select preliminary unaudited financial results for...
ExCellThera rencontr
ExCellThera rencontrera les investisseurs durant la 42e conférence annuelle J.P. Morgan Healthcare et participera aux prochaines conférences d'investisseurs
January 02, 2024 07:00 ET | ExCellThera
MONTREAL, 02 janv. 2024 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), un leader mondial des thérapies à base de cellules souches sanguines amplifiées, a annoncé aujourd'hui que ses hauts...
ExCellThera to Condu
ExCellThera to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference and to Participate in Upcoming Investor Conferences
January 02, 2024 07:00 ET | ExCellThera
ExCellThera senior leaders will be holding investor meetings during JP Morgan Heathcare Conference and participating in upcoming investor conferences.
ITM_Logo_Claim_RGB_high-res.png
ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 21, 2023 08:00 ET | ITM Isotope Technologies Munich SE
Garching / Munich, Germany, December 21, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that CEO, Steffen Schuster and CFO, Dr. Klaus...
SG-Logo.png
SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
December 14, 2023 12:43 ET | SOPHiA GENETICS, Inc.
BOSTON and ROLLE, Switzerland, Dec. 14, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (NASDAQ: SOPH) today announced that Jurgi Camblong, PhD., Chief Executive Officer and Co-founder, is scheduled to...
PRimage.jpg
FIRST REPUBLIC BANK INVESTOR ALERT: Kaplan Fox Announces Investigation of First Republic Bank on Behalf of Investors
March 16, 2023 15:57 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of First Republic Bank (“First Republic” or the...